In this study, we aimed to determine whether skeletal muscle cells per se are a source of interleukin (IL)-6 during contraction and whether IL-6 production is fiber type specific. Muscle biopsy samples were collected from seven males before (PRE) and after (POST) completing 120 min of continuous bicycle ergometry. Biopsies were sectioned and analyzed for the following: IL-6 protein detected by immunohistochemistry (IHC), IL-6 mRNA content detected by in situ hybridization, fiber type measured by either IHC or myofibrillar ATPase activity stain, and glycogen content measured by periodic acid schiff (PAS) assay. Fibers were qualitatively categorized according to glycogen content to one of five groups (1-5), with 1 being very low (LOW) and 5 being very high (HIGH) glycogen. Total fluorescence (PRE vs. POST) and glycogen-dependent fluorescence (LOW vs. HIGH) of IL-6 protein were quantitated using Metamorph software. Total IL-6 protein was elevated from PRE to POST exercise (P<0.05). At PRE, IL-6 protein was evenly distributed across all fibers at low levels, consistent with glycogen distribution. At POST, IL-6 protein was greater (P<0.05) in HIGH compared with LOW glycogen fibers, which coincided with type 2 fibers. IL-6 mRNA was distributed peripherally in all fibers at PRE. At POST, however, IL-6 mRNA appeared predominantly in type 2 fibers, which also had higher glycogen content (P<0.05). These data demonstrate that myocytes per se are a source of IL-6 produced during contraction. Our data also suggest that type 2 fibers predominantly produce IL-6 during muscle contractile activity.
fibroblasts, endothelial cells, and macrophages, and these cells are also known to produce IL-6 (4-7). Therefore, it is possible that the elevation in IL-6 gene expression in biopsy tissue and IL-6 protein release may be due to cells other than skeletal myocytes. In support of this hypothesis, Malm et al. (8) detected IL-6 protein in both muscle and nonmuscle cells using immunohistochemical staining of muscle biopsies taken before and after acute contraction, but they did not show any change in the amount of IL-6 protein as a result of muscle contraction. Recently, however, Penkowa et al. (9) reported a qualitative elevation in IL-6 protein measured in muscle cells within human muscle biopsy sections by immunohistochemistry. In that study, IL-6 was uniformly expressed throughout each fiber, and the authors also noted that IL-6 expression was not different between fiber types. These data lend support to the hypothesis that IL-6 is produced in, and released in, muscle tissue but does not necessarily confirm that myocytes are a source of IL-6 production, because the authors could not rule out the possibility that cells other than myocytes produced the IL-6, which then trafficked into the muscle cells to perform important functions such as the initiation of a stress protein response (10) .
In the present study, we aimed to determine whether muscle cells per se are the source of the exercise-induced elevation in IL-6 in human skeletal muscle and to characterize the distribution of IL-6 within and between fibers. An analysis of both IL-6 protein and mRNA expression within sectioned muscle biopsy tissue, collected before and after contraction, and further characterization of the fiber type and glycogen content of each fiber was performed. By simultaneously examining the cellular localization of the IL-6 gene and protein within fiber cross sections, this study could categorically determine whether muscle cells are indeed a source of IL-6 during contraction. We hypothesized that IL-6 mRNA and protein would be increased within myocytes following exercise and that this would correspond with glycogen-depleted fibers.
MATERIALS AND METHODS

Subjects and experimental protocol
Seven healthy, active males volunteered to participate in this investigation. Subjects signed a written consent form after being informed of all procedures and potential risks of the study, which was approved by the appropriate Ethics Committee. Subjects performed 120 min of continuous cycle ergometry at a power output equivalent to ~55% of their individual peak oxygen consumption ( · VO 2 peak ).
Muscle biopsies were obtained from vastus lateralis muscle before (PRE) and after (POST) exercise using the percutaneous needle method with suction under local anesthesia. Immediately following each biopsy, muscle tissue was removed from the needle using sterile tweezers and separated into two sections: one of these was immediately frozen in liquid nitrogen, and one was mounted in TissueTek (Fronine, Riverstone, Australia), frozen in isopentane (BDH Laboratory Supplies, Poole, UK) over liquid nitrogen, and stored at -80°C until later analysis.
Histological preparation
Multiple 10 µm sections were cut from mounted muscle biopsy samples in a cryostat at -20°C. Sections were fixed onto gelatin-coated microscope slides by immersion in 5% paraformaldehyde (PFA) for 5 min and 70% ethanol for 5 min, air dried, and stored at -80°C until required for analysis. For fiber type analysis, three sections were placed on uncoated microscope coverslips and stored at 4°C until required.
Immunohistochemical staining for human IL-6 protein IL-6 protein was detected in muscle fiber cross-sections. In brief, sections were washed in 5% Triton X (Sigma-Aldrich, Castle Hill, Australia) for 10 min and then washed twice with 0.02 M phosphate-buffered saline (PBS) and allowed to dry. Sections were then blocked overnight with 3% sheep serum (Silenus Laboratories, Melbourne, Australia). The next day, sections were washed three times in PBS and incubated overnight with a rabbit polyclonal IL-6 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) in a 1:20 dilution in 1% sheep serum at 4°C. Negative slides were prepared using 1% sheep serum in the absence of the primary antibody. The following day, sections were washed three times with PBS and labeled with a fluorescein conjugated anti-rabbit secondary antibody (Santa Cruz Biotechnology) (1:50 dilution in 1% sheep serum) for 2 h at room temperature in the dark. After three washes in PBS, sections were air dried and mounted in Fluoroguard (Bio-Rad Laboratories, Hercules, CA). Coverslips were sealed with clear nail polish and allowed to dry.
The IHC methodology described above was optimized before sample analysis to provide clear fluorescence with minimal nonspecific binding (background). Several concentrations of primary antibody were detected by the secondary antibodies fluorescein, Texas Red, and biotinylated streptovidin-peroxidase complex. We found that detection with Texas Red and biotinylated streptovidin-peroxidase showed consistently high background, suggesting high levels of nonspecific binding. Thus, we chose to analyze our samples using fluorescein.
Detection and quantitation of IL-6 protein
IL-6 protein was visualized using an Olympus BX60 (Olympus Optical Company, Hamburg, Germany) fluorescent microscope, and multiple images were captured by a Sensicam Imaging camera controlled by Camware software (version 1.21, PCO Imaging, Kelheim, Germany). For both positively and negatively stained slides, three images were captured on each of three sections. Thus, nine sections were captured for each subject at each time point. Fluorescence intensity was quantitated using Metamorph software (version 4.6, Universal Imaging Corporation, Downingtown, PA). Mean intensity was measured on each image, and total mean fluorescence was calculated for each sample. To exclude background fluorescence, we subtracted quantitated data for the negative slides from the data from positive slides, and mean fluorescence was compared between PRE and POST samples.
Comparison of IL-6 fluorescence between glycogen-rich and glycogen-poor fibers
Muscle fiber glycogen content was qualitatively assessed on sectioned biopsy tissue using Periodic Acid-Schiff Staining (PAS) as described previously (11) . This assay is used to visualize glycols by producing a magenta stain that is proportional to the amount of glycogen in each cross sectioned muscle fiber. As expected, glycogen content was uniformly rich in samples collected before exercise and, therefore, these were not classified. In post-exercise samples, however, each fiber was classified as being rich, moderate, or poor in glycogen content using a visual scale. To examine whether individual fiber glycogen content was associated with IL-6 fluorescence following exercise, three glycogen-poor and three glycogen-rich fibers from each section were outlined and quantitated. These fibers were matched to their identical fibers in the IL-6 IHC sections, and these fibers were quantitated using Metamorph software. In essence, we compared IL-6 protein between glycogen-rich and glycogen-poor fibers.
Fiber typing
Muscle fiber type was determined in 10 µm sections by one of two methods: staining for myofibrillar ATPase activity after preincubation with alkaline or acidic buffers, as described elsewhere (12), which stains type 2 muscle fibers a dark color, or by IHC, essentially as described above for IL-6 protein, except that the primary antibody used was a mouse anti-slow muscle myosin monoclonal antibody (which detects type 1 fibers) (Chemicon International, Temecula, CA) diluted 1:500 in 1% sheep serum, and the secondary antibody used was a fluorescein conjugated anti-mouse (Santa Cruz Biotechnology) diluted 1:50 in 1% sheep serum. Sections were washed, air dried, mounted, and sealed as described above. We initially used the myofibrillar ATPase activity when performing comparisons with IL-6 protein. However, we found that this method resulted in shrinkage of the fibers (Fig. 1) , making it more difficult to match the sections with the IL-6 protein and PAS cross sections. Hence, when subsequently performing the in situ hybridization analyses, we used the IHC method (Fig. 4) . We suggest, therefore, that this method is superior because it does not affect the size of the muscle fibers.
In situ hybridization
The IL-6 probe used was derived from a 1.23 kb human sequence. The antisense probe for human IL-6 was linearized with EcoR1 and labeled using T7 polymerase with 33 P-UTP for 2 h at 37°C. The probe was hydrolyzed by exposure to alkaline pH for 50 min to produce a probe length of ~0.15 kb. The labeled probe was counted on a scintillation counter and diluted in hybridization buffer to a final concentration of 40 × 10 6 dpm/ml -1 . In situ hybridization was carried out on 10 µm frozen sections of tissue from each of the pre-and post-exercise biopsies. Sections were fixed by immersion in buffered 4% paraformaldehyde, washed in PBS, and then stored at -20°C after dehydration in 70% ethanol. Metastatic breast tissue sections were prepared in an identical manner to act as positive controls. Pretreatment of sections before hybridization was carried out by microwaving in antigen retrieval solution (Citra Plus, BioGenex, San Ramon, CA), followed by incubation in pronase E (Sigma, St. Louis, MO) at a concentration of 125 µg/ml -1 for 10 min at 37°C. Hybridization was carried out overnight in hybridization buffer containing 50% formamide at 60°C. Posthybridization washes were performed in 50% formamide/2× SSC at 55°C. In addition, unbound probe was removed by incubation of sections in RNase A (Sigma, St Louis, MO) at a concentration of 125 µg/ml -1 at 37°C for 1 h. Positive signals were detected using Amersham (Little Chalfont Buckinghamshire, UK) LM-1 emulsion and development in Kodak (Rochester, NY) Dektol developer, then fixation in Ilford Hypam (Cheshire, UK) rapid fixer. Slides were lightly counterstained with hematoxylin and viewed using a dark-field condenser.
Measurement of IL-6 mRNA in muscle biopsies by RT-PCR
Total RNA was extracted using the acid phenol method of Chomczynski and Sacchi (13) and reverse transcribed using Taqman Reverse Transcription Reagents, using random hexamer primers, according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). IL-6 mRNA was detected using real-time PCR as described previously (14) . For each sample, the IL-6 mRNA content was normalized to the housekeeping gene 18S (given a ∆Ct value). All samples from a given subject was expressed as fold changes relative to the pre value, which was set to 1, using the ∆∆Ct method (Applied Biosystems).
Statistical analysis
Paired t tests were used to detect the effect of contraction on quantitated total IL-6 protein (PRE vs. POST), and IL-6 protein in HIGH and LOW glycogen fibers. P < 0.05 was considered to indicate statistical significance. Data are expressed as mean ± SE. Statistical analyses were performed using SigmaStat version 2.03 (SPSS, Inc., Chicago, IL).
RESULTS
IL-6 protein is elevated after exercise in skeletal muscle fibers
IL-6 protein was elevated in muscle biopsy cross-sectional tissue from PRE to POST contraction (P<0.05) that could clearly be observed both within and between muscle fibers ( Fig. 1 and 2 ). At PRE, IL-6 protein was uniformly expressed across muscle fibers at low levels ( Fig. 1) . At POST, however, IL-6 protein was expressed in a fiber-specific manner. The distribution of IL-6 protein was then examined by quantitatively comparing muscle fibers with LOW glycogen content (type 1 fibers) and fibers with HIGH glycogen content (type 2 fibers) at POST. This analysis revealed that IL-6 protein was expressed predominantly in type 2 muscle fibers with HIGH glycogen content (P<0.05) (Fig. 3 ).
IL-6 mRNA is elevated after exercise in skeletal muscle fibers
IL-6 mRNA, as measured by real-time RT-PCR, was increased (P<0.05) 18 ± 8-fold when comparing PRE with POST. As can be seen in Figure 4 , this coincided with an increase in IL-6 mRNA, as measured by in situ hybridization, within skeletal muscle fibers comparing PRE with POST contraction. At PRE, IL-6 mRNA was expressed peripherally at low levels around all fibers, and there was a virtual absence of IL-6 in the center of the myocytes, suggesting that, at rest, IL-6 in skeletal muscle tissue is likely to be located in cell types other than myocytes (7) . However, at POST, IL-6 mRNA was selectively expressed throughout some, but not all, muscle fibers (Fig. 4) . Further examination of these fibers showed that type 2 fibers were expressing IL-6 mRNA at a much greater level than type 1 fibers and that these fibers also had greater glycogen content (Fig. 4) DISCUSSION Our data clearly demonstrate that human skeletal myocytes per se are a source of contractioninduced IL-6. Furthermore, we provide solid evidence that IL-6 is predominantly produced by type 2 fibers. This is the first study to identify that during muscle contraction, IL-6 is produced within muscle cells. In a recent study by Penkowa et al. (9) , IL-6 protein was detected within muscle fibers and shown to increase following acute contraction. However, although the increase in IL-6 protein reported in this previous study (9) showed that IL-6 protein was indeed increased in muscle cells, the authors did not measure IL-6 mRNA cellular localization. Therefore, this previous study, while providing a good indication that myocytes were a source of IL-6 during contraction, could not definitively prove this to be so, because it was possible that IL-6 was produced by other cell types before being trafficked into the muscle cell to perform intracellular roles. By using in situ hybridization to determine the cellular localization of IL-6, coupled with the quantitatively analyzed IL-6 protein within muscle fibers using IHC detection, our data provide the first solid evidence that human skeletal myocytes indeed produce IL-6 in response to contraction.
Our IL-6 protein data differ somewhat from that reported by Penkowa et al. (9) , who showed that IL-6 protein was distributed homogenously across each muscle fiber and did not appear to vary between fiber types. In contrast, the distribution of IL-6 protein after contraction in the current study could clearly be detected in predominantly type 2 fibers. It is difficult to identify the cause of this disparity between studies, given that both studies used a prolonged concentric model of contraction and the sampling methodologies of each study were similar. However, as reported in our methods, our optimization for IHC not only included fluorescein as a secondary antibody, but also biotinylated streptovidin-peroxidase and Texas Red tagged secondary antibodies. We found that these two latter antibodies were less effective than fluorescein in eliminating background expression, and it is possible that the difference when comparing the results from the study of Penkowa et al. with the present study was the choice of the secondary antibody. Irrespective of why our data differ with those of Penkowa et al., we are confident that our protein data are an accurate representation of the fiber distribution of IL-6 because they are very consistent with our in situ hybridization data.
Our data reporting that IL-6 protein and mRNA expression was located in predominantly type 2 fibers with high glycogen content after contraction is an important novel finding. This finding was very surprising to us, and contrary to our hypothesis, which was based on the consistent previous finding that IL-6 mRNA expression and protein release is exacerbated with glycogen depletion (2, 15) . However, it is well known that during prolonged steady-state cycling, exercise muscle glycogenolysis occurs predominantly in type 1 fibers, and glycogenolysis in the type 2 fibers only occurs when type 1 fibers are glycogen depleted (16) . Given our data that IL-6 protein and mRNA are present in predominantly type 2 fibers, we propose that an augmented increase in IL-6 mRNA and protein release is evident with low pre-exercise glycogen content because type 1 fibers become glycogen depleted earlier, resulting in the earlier recruitment of type 2 fibers.
If lowered glycogen is not directly involved in the regulation of myocyte-derived IL-6, what other factors might be involved? It has been recently hypothesized that an increase in contraction-induced cytosolic Ca 2+ levels may be one factor (1), based on data implicating intracellular Ca 2+ ion concentration in the regulation of IL-6 gene transcription in other cell types (17) and on the fact that acute muscle contraction induces a rapid shift in the release of Ca 2+ from the sarcoplasmic reticulum (SR) to the cytosol (18) . Two preliminary studies have shown that the Ca 2+ ionophore ionomycin results in an increase in IL-6 mRNA in human primary skeletal muscle cell cultures (19) and rat skeletal muscle in vitro (20) , providing some evidence that Ca 2+ may regulate IL-6 gene transcription. In the context of the current investigation, the importance of cytosolic Ca 2+ in the regulation of IL-6 would be supported by fiber-specific differences in Ca 2+ release characteristics. Recently, in a study by Baylor and Hollingsworth (21) , action potential-stimulated total Ca 2+ release and rate of release were compared in isolated predominantly slow twitch (soleus) and predominantly fast twitch (extensor digitorum longus) muscle fibers of the mouse. The authors showed a threefold greater total and peak rate of release in the fast twitch (type 2) fibers. If these data were to hold true for human skeletal muscle, it is likely that contraction would also induce a greater release of Ca 2+ in type 2 fibers, and this enhanced release might be linked to an increased induction and translation of IL-6 in these fibers.
In conclusion, prolonged continuous contraction induced an increase in IL-6 protein and mRNA content that was predominantly located in type 2 muscle fibers. 
